These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7882575)

  • 21. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
    Scheuermann M; Dietz R; Willenbrock R
    Eur J Pharmacol; 1998 Apr; 347(2-3):245-52. PubMed ID: 9653889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of intravenous injection of alpha-human atrial natriuretic polypeptide on blood pressure, renal hemodynamics and urinary kinin excretion in anesthetized rabbits.
    Nushiro N; Abe K; Seino M; Omata K; Yoshinaga K
    Tohoku J Exp Med; 1987 Feb; 151(2):221-31. PubMed ID: 2953089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
    Biollaz J; Bidiville J; Diézi J; Waeber B; Nussberger J; Brunner-Ferber F; Gomez HJ; Brunner HR
    Kidney Int; 1987 Oct; 32(4):537-46. PubMed ID: 2963166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids potentiate the action of atrial natriuretic polypeptide in adrenalectomized rats.
    Hayamizu S; Kanda K; Ohmori S; Murata Y; Seo H
    Endocrinology; 1994 Dec; 135(6):2459-64. PubMed ID: 7988432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive rats.
    Seymour AA; Swerdel JN; Fennell SA; Delaney NG
    Life Sci; 1988; 43(26):2265-74. PubMed ID: 2974913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the renal response to atrial natriuretic peptide by sodium intake in preweaned rats.
    Chevalier RL; Muchant DG; Thornhill BA; Belmonte DC; Pence RA; Baertschi AJ
    Pediatr Res; 1996 Aug; 40(2):294-9. PubMed ID: 8827780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
    Margulies KB; Cavero PG; Seymour AA; Delaney NG; Burnett JC
    Kidney Int; 1990 Jul; 38(1):67-72. PubMed ID: 2143548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
    Mendez RE; Dunn BR; Troy JL; Brenner BM
    Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An oxidized analog of alpha-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase.
    Koyama S; Terai T; Inoue T; Inomata K; Tamura K; Kobayashi Y; Kyogoku Y; Kobayashi M
    Eur J Biochem; 1992 Feb; 203(3):425-32. PubMed ID: 1346519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
    Lipkin GW; Dawnay AB; Harwood SM; Cattell WR; Raine AE
    Kidney Int; 1997 Sep; 52(3):792-801. PubMed ID: 9291201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.